Spanish Lung Cancer Group

Quick facts

Phase 3 pipeline

• Docetaxel/Cisplatin control · Oncology
  This combination uses docetaxel (a microtubule-stabilizing taxane) and cisplatin (a platinum-based DNA-damaging agent) to inhibit cell division and induce apoptosis in lung cancer cells.

Phase 2 pipeline

• paclitaxel, carboplatin and bevacizumab
• Tirosin Kinase Inhibitors

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Spanish Lung Cancer Group portfolio CI brief
• Spanish Lung Cancer Group pipeline updates RSS